LONDON (Reuters) - U.S. drugmaker Mylan is recalling batches of the injectable antibiotic clarithromycin made in India due to possible impurities, Britain's healthcare regulator said on Wednesday.The Medicines and Healthcare products Regulatory Agency, or MHRA, said the decision was due to the potential for small particles of white material to be present in individual vials.The Mylan recall is being made on behalf of Strides Arcolab International and relates to Agila-branded supplies, the MHRA added. The Pennsylvania-based company bought Agila, a unit of India's Strides Arcolab , for $1.6 ...
MORE ON MARKETS:
Copyrights © 2020 Business Standard Private Ltd. All rights reserved.
Upgrade To Premium Services
Business Standard is happy to inform you of the launch of "Business Standard Premium Services"
As a premium subscriber you get an across device unfettered access to a range of services which include:
- Access Exclusive content - articles, features & opinion pieces
- Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
- Access to 17 plus years of content archives
- Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
- End of day news alerts on 5 companies (via email)
- NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
In Partnership with
Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.
Team Business Standard